Abstract Objective To evaluate the effect of infliximab on progression of structural damage over 2 years in patients with ankylosing spondylitis (AS). Methods In the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy (ASSERT), a randomized, double‐blind, placebo‐contro...
No comments yet
Be the first to share your thoughts!